These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15597802)

  • 1. [The usage of therapeutic drugs and its valuation].
    Endo S; Sato N
    Nihon Rinsho; 2004 Dec; 62(12):2313-6. PubMed ID: 15597802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Understanding the pathogenetic mechanisms of SIRS and sepsis and development of innovative therapies of sepsis].
    Aikawa N; Fujishima S
    Nihon Rinsho; 2004 Dec; 62(12):2173-6. PubMed ID: 15597781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome.
    Berger MM; Chioléro RL
    Crit Care Med; 2007 Sep; 35(9 Suppl):S584-90. PubMed ID: 17713413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activated protein C (the impact of PROWESS trial)].
    Iba T; Kidokoro A
    Nihon Rinsho; 2004 Dec; 62(12):2296-300. PubMed ID: 15597799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of sepsis.
    Girbes AR; Beishuizen A; Strack van Schijndel RJ
    Fundam Clin Pharmacol; 2008 Aug; 22(4):355-61. PubMed ID: 18705746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock.
    Wheatley C
    Med Hypotheses; 2006; 67(1):124-42. PubMed ID: 16545917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis.
    Minneci P; Deans K; Natanson C; Eichacker PQ
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):1-9. PubMed ID: 12582737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing.
    Bouman CS; Oudemans-van Straaten HM; Schultz MJ; Vroom MB
    J Crit Care; 2007 Mar; 22(1):1-12. PubMed ID: 17371737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical comparison of the hematologic, cardiovascular, and pulmonary response to steroids and nonsteroidal anti-inflammatory drugs in a model of sepsis and adult respiratory distress syndrome.
    Kopolovic R; Thraikill KM; Martin DT; Carey LC; Cloutier CT
    Surgery; 1986 Oct; 100(4):679-90. PubMed ID: 3764692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-inflammatory treatment in sepsis].
    Bloos F; Reinhart K
    Chirurg; 2002 Nov; 73(11):1087-92. PubMed ID: 12430058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical data on the use of selenase in sepsis].
    Lehmann Ch
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 11():S411-3. PubMed ID: 19998233
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of empiric antibiotic use in surgical sepsis.
    Fitousis K; Moore LJ; Hall J; Moore FA; Pass S
    Am J Surg; 2010 Dec; 200(6):776-82; discussion 782. PubMed ID: 21146020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory therapies in sepsis and septic shock.
    Freeman BD; Natanson C
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1651-63. PubMed ID: 11060768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the understanding of clinical manifestations and therapy of severe sepsis: an update for critical care nurses.
    Ely EW; Kleinpell RM; Goyette RE
    Am J Crit Care; 2003 Mar; 12(2):120-33; quiz 134-5. PubMed ID: 12625170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of severe sepsis at a German university hospital].
    Audebert FX; Hanses F; Schneidewind A; Ehrenstein B; Blaas S; Salzberger B; Schölmerich J; Fröhlich D; Straub RH; Glück T
    Med Klin (Munich); 2007 Mar; 102(3):195-202. PubMed ID: 17345015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of systemic inflammatory response syndrome and multiple organ dysfunction syndrome in critically patients].
    Qiu H; Du B; Liu D
    Zhonghua Wai Ke Za Zhi; 1997 Jul; 35(7):402-5. PubMed ID: 10677973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis.
    Deng HP; Chai JK
    Int Immunopharmacol; 2009 Oct; 9(11):1251-9. PubMed ID: 19647101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.